Ismail, J.; Klepsch, L.C.; Dahlke, P.; Tsarenko, E.; Vollrath, A.; Pretzel, D.; Jordan, P.M.; Rezaei, K.; Czaplewska, J.A.; Stumpf, S.;
et al. PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs. Pharmaceutics 2024, 16, 187.
https://doi.org/10.3390/pharmaceutics16020187
AMA Style
Ismail J, Klepsch LC, Dahlke P, Tsarenko E, Vollrath A, Pretzel D, Jordan PM, Rezaei K, Czaplewska JA, Stumpf S,
et al. PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs. Pharmaceutics. 2024; 16(2):187.
https://doi.org/10.3390/pharmaceutics16020187
Chicago/Turabian Style
Ismail, Jana, Lea C. Klepsch, Philipp Dahlke, Ekaterina Tsarenko, Antje Vollrath, David Pretzel, Paul M. Jordan, Kourosh Rezaei, Justyna A. Czaplewska, Steffi Stumpf,
and et al. 2024. "PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs" Pharmaceutics 16, no. 2: 187.
https://doi.org/10.3390/pharmaceutics16020187
APA Style
Ismail, J., Klepsch, L. C., Dahlke, P., Tsarenko, E., Vollrath, A., Pretzel, D., Jordan, P. M., Rezaei, K., Czaplewska, J. A., Stumpf, S., Beringer-Siemers, B., Nischang, I., Hoeppener, S., Werz, O., & Schubert, U. S.
(2024). PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs. Pharmaceutics, 16(2), 187.
https://doi.org/10.3390/pharmaceutics16020187